After the China International Beauty Expo: How Can Brands Enter the Microcrystal Patch Market? (Translation)

The 69th China International Beauty Expo took place at Guangzhou's Pazhou Canton Fair complex on 10–12 March 2026. The original report describes more than 3,000 exhibitors and 300,000 square metres of exhibition space.

Questions from brands

Eye-care patches, blemish-care patches and other microcrystal concepts drew questions from brand teams, product managers and development engineers. Two recurring questions were where to start without in-house microneedle expertise and how to secure consistent supply. The discussion was moving from whether a patch could be made to whether it could be manufactured reliably.

Three signals from the exhibition

• From ingredients to delivery technology: brands were exploring how patch structure and formulation could help differentiate localised skincare products.
• From a single product to a portfolio: eye care remained prominent, alongside blemish-care and new night-patch concepts. Each category requires its own evidence and regulatory assessment.
• From marketing concepts to execution: technical capability, response time and appropriate qualifications were becoming important supplier-selection criteria.

Connecting brand demand with development capability

The source describes more than two decades of research led by founder Yunhua Gao and the RT-SMP® process, which received an “internationally advanced” technology assessment in 2022. CASMN combines its Beijing R&D base with Chongqing manufacturing; the report states annual cosmetic-patch capacity of 150 million patches.

ISO 22716, GMPC, ISO 9001 and ISO 13485 are among the systems listed in the original report. OEM/ODM discussions cover formulation, product format and manufacturing requirements, with the final scope determined for each project.